CJC-1295 With DAC: Handling, Storage, and Reconstitution Guide

Sound CJC-1295 With DAC handling and storage practice preserves the integrity of a lyophilized long-acting GHRH analog across the extended study windows it is often used for. This guide covers laboratory best practice for storage, reconstitution for in-vitro preparation, aliquoting, and documentation. It describes laboratory workflows only and is not human-use guidance.

CJC-1295 With DAC Handling and Storage Fundamentals

CJC-1295 With DAC (C165H269N47O46, CAS 446262-90-4, molecular weight near 3647.2 g/mol) ships as a solid, white lyophilized powder in a sealed glass vial. Keep it sealed, cool, dry, and shielded from light until preparation. Because the compound is frequently used in sustained-signaling designs, described in the CJC-1295 With DAC research applications, stable handling across a long study window is especially important. A study that runs for days is only as reliable as the stimulus that persists through it.

The confirmed molecular weight supports exact concentration and molar calculations from the vial mass, which is the foundation of a reproducible working stock and a prerequisite for comparing results across laboratories.

Recommended Storage Conditions

Store lyophilized material at 25 degrees Celsius or below, sealed, away from heat, light, and moisture. For extended storage, keep the peptide lyophilized and refrigerated or frozen. Holding conditions steady throughout a study period supports both stability and reproducible results.

• Sealed lyophilized vial, protected from heat, light, and humidity.
• Refrigerated or frozen storage for extended holding periods.
• Storage records maintained as part of routine quality assurance.

The lyophilized form is more stable than material in solution, so the powder should be preserved until it is needed wherever the design allows. A documented cold chain lets any anomalous result be traced to biology rather than to a storage lapse, which is particularly valuable in the long time courses this compound supports. When a study spans days, a single unrecorded excursion in storage temperature can undermine an entire arm, so consistent conditions and complete records are worth the routine effort they require.

Reconstitution for In-Vitro Preparation

For laboratory preparation, the lyophilized peptide is typically reconstituted with bacteriostatic water or a solvent appropriate to the assay. Direct the solvent slowly against the vial wall rather than onto the powder, and allow it to dissolve without vigorous shaking, which can stress the peptide in solution. The maleimide-bearing DAC group is chemically reactive by design, so avoid conditions or additives that could compromise it before the material reaches its intended assay. Reconstitution produces in-vitro working stocks and is not an administration step.

The reactivity of the DAC group is precisely what confers the compound's extended duration, so protecting it during preparation is essential to preserving the sustained-signaling behavior the study depends on. Gentle handling and appropriate solvent choice keep the group intact until it engages albumin in the intended assay context.

Aliquoting and Freeze-Thaw Management

After reconstitution, dividing the solution into single-use aliquots limits repeated freeze-thaw cycles, a common cause of peptide degradation. Label each aliquot with compound, concentration, and date, keep reconstituted material refrigerated, and use it within the timeframe indicated by your protocol. This discipline parallels the CJC-1295 No DAC handling guide and the Sermorelin handling guide.

For the DAC form, single-use aliquots serve a second purpose: they minimize the number of times the reactive group is exposed to freeze-thaw stress, helping preserve its albumin-binding capacity across the replicates of a sustained-signaling study.

Lot and Certificate of Analysis Verification

Every batch ships with a third-party-verified certificate of analysis documenting purity by HPLC or reverse-phase chromatography, mass-spectrometry identity confirmation, and lot number, testing date, and method. Record the lot against your experimental records so results trace back to a specific batch, and request sample COAs ahead of purchase to confirm testing parameters. The signaling basis these controls protect is covered in the CJC-1295 With DAC mechanism of action.

Carrying a single verified lot through a long study removes batch variation as a confound, which matters most in extended designs where inconsistencies can accumulate across the time course.

Documentation and Traceability

Follow institutional SOPs, chemical hygiene plans, and approved protocols, and wear appropriate PPE. Record lot numbers, storage conditions, and handling activities, and retain COAs and batch documentation to support traceability and audit readiness. Building these records into routine bench work keeps a study reproducible and audit-ready rather than requiring reconstruction after the fact.

A complete chain from vial to result is what lets a sustained-signaling finding withstand review and be reproduced by another laboratory.

Protecting the Reactive DAC Group in Solution

The maleimide-bearing Drug Affinity Complex is what gives the compound its extended duration, and it is also the feature most vulnerable during handling. Maleimide chemistry is sensitive to conditions such as elevated pH and to competing thiols, so solvent choice and additive selection should protect the group until it is meant to engage albumin in the intended assay context. Thiol-containing buffers or reducing agents introduced before that point can quench the group and blunt the very sustained-signaling behavior the study aims to observe.

In practice this means the DAC form rewards a slightly more deliberate preparation than a non-reactive peptide. Gentle reconstitution, an appropriate solvent, and prompt aliquoting all help preserve the group's albumin-binding capacity across the replicates of a long study. Because a quenched or hydrolyzed maleimide would shorten the effective duration without any visible change to the material, this is a failure mode that ordinary purity checks may not catch, which is another reason the reactive group is worth protecting deliberately from the moment of reconstitution. Current batch documentation is available on the CJC-1295 With DAC product page, and keeping the reactive group intact from vial to assay is central to reproducing the compound's extended-duration profile.

For research use only. CJC-1295 With DAC is an investigational research peptide and is not approved for human or veterinary use. All handling described here refers to laboratory preparation for in vitro and preclinical research.